Jiangsu Hualan New Pharmaceutical Material Co., Ltd. held its 2nd Extraordinary General Meeting of 2022 on 22 March 2022 approved the appointment of Hua Guoping, Hua Yimin, Li Lun, Xiao Feng, Ma Weiguo, Wang Zhaoqian as non-independent directors and Liu Dan, Liu Li, Xu Zuojun as independent directors.
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
Equities
301093
CNE100004YH2
Tires & Rubber Products
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.26 CNY | -1.94% | +2.92% | -27.99% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.99% | 414M | |
+17.88% | 30.23B | |
+14.36% | 28.58B | |
+45.19% | 7.45B | |
+26.42% | 4.21B | |
-9.50% | 3.69B | |
-1.54% | 3.6B | |
+49.29% | 3.45B | |
+24.02% | 3.21B | |
+23.81% | 2.89B |
- Stock Market
- Equities
- 301093 Stock
- News Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
- Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Announces Executive Changes